Muhammed Gomec
- 17年の経験
- 所在地: トルコ, スィヴァス
トルコのトップ前立腺癌に対する免疫療法医師と価格を比較。こちらで最適なマッチングを見つけてください
ご要望と予算に基づいて最適な医師を厳選いたします
医学的監修者 Fahad Mawlood
医学編集者・データサイエンティストトップ医師
2
トルコ
レビュー
14000+
実際の患者より
トップ各国の前立腺癌に対する免疫療法価格を比較
国をタップしてトップ医師と価格を表示
個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし
海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。
ヤン・マツィイフスキー
医療コーディネーターチーム責任者
4300+件以上の患者の旅をガイド
Bookimedで3年
Turkeyの278名の患者が今月当社を通じて医師を見つけました
2分のクイズ
目標、予算、スケジュールをお聞かせください
人間のマッチング + AI
アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します
オプション準備完了
価格、パッケージ、日程を比較。コーディネーターとチャット
選択肢に迷っていますか?
治療をガイド
医療訓練を受けた専属コーディネーター






| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|
Top immunotherapy doctors in Turkey are medical oncologists with academic titles like Professor or Associate Professor. They hold European Society for Medical Oncology (ESMO) certification and specialize in molecular tumor biology. These experts practice in JCI-accredited centers that collaborate with major international medical institutions.
Bookimed Expert Insight: Data shows that top-tier Turkish oncologists often integrate molecular diagnostics into personalized care. For instance, Dr. Cemil Bilir trained at the Cleveland Clinic in nanomedicine, while Dr. Yesim Yildirim has published 80+ papers. This research-heavy background is crucial for determining if a patient is eligible for specific immunotherapy drugs based on genetic markers.
Patient Consensus: Patients note it is important to choose doctors who explain why immunotherapy fits their specific cancer subtype. They often feel more confident with specialists who work in multidisciplinary teams alongside urologists. Many suggest asking how the doctor manages potential immune-related side effects during treatment.
Turkish medical oncologists provide access to advanced prostate cancer protocols using checkpoint inhibitors and targeted therapies. While CAR-T remains experimental for solid tumors, specialists at Anadolu Medical Center and Hisar Hospital integrate international expertise from MD Anderson and Johns Hopkins Medicine to manage complex cases.
Bookimed Expert Insight: Data shows that premier Turkish centers often serve as extension hubs for American standards. For example, Anadolu Medical Center's affiliation with Johns Hopkins Medicine allows doctors to provide molecular profiling. This ensures patients receive immunotherapy tracks aligned with US clinical protocols. Expert consultations are available starting from $100 with Dr. Mustafa Solak and $215 with specialists at Anadolu.
Patient Consensus: Patients note it is important to clarify the specific type of immunotherapy before traveling. Many say they had to distinguish between standard drug treatments and experimental clinical trials. Those who traveled emphasize that clear communication about cell therapy types helped manage their expectations.
Verifying a doctor's expertise in prostate cancer immunotherapy requires analyzing their academic research history and clinical certifications. In Turkey, top oncologists combine intensive clinical practice with roles in international trials. You should prioritize doctors with European Society for Medical Oncology certification and active records in peer-reviewed research.
Bookimed Expert Insight: For complex prostate cases, the most experienced doctors in Turkey often hold joint appointments as university professors. Dr. Yesim Yildirim and Dr. Bulent Karagoz both balance clinical work with academic leadership. This ensures they are using the latest immunotherapy protocols long before they become standard practice. Patients may also book consultations with these specialists starting from $215.
Patient Consensus: Patients note it's important to ask how many immunotherapy cases the doctor handled in the last year. They recommend checking if the surgeon participates in multidisciplinary boards rather than making solo treatment decisions. Many were surprised by the depth of detail doctors provided about specific biomarkers during the initial consultation.
Turkish oncologists provide personalised immunotherapy for prostate cancer using biomarker profiling and genetic sequencing. Specialists like Dr. Bulent Karagoz and Dr. Yesim Yildirim at Anadolu Medical Center design precision protocols. These treatments align with international standards set by the European Society for Medical Oncology (ESMO).
Bookimed Expert Insight: While immunotherapy is often linked to academic centers, Turkish experts bridge the gap between research and practice. Dr. Nail Paksoy and Dr. Cemil Bilir integrate nanomedicine and clinical trial data directly into patient care. This ensures that even rare biomarker-positive cases receive protocols often found only at major global research institutes.
Patient Consensus: Patients note that biomarker testing is the essential first step before starting any therapy. They emphasize the importance of confirming genetic markers like MSI-high to ensure a drug will work. Many felt more confident after having their genomic reports reviewed by a multidisciplinary oncology board.